De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease
Molecular Psychiatry2015Vol. 20(9), pp. 1046–1056
Citations Over TimeTop 10% of 2015 papers
Anne Rovelet‐Lecrux, Camille Charbonnier, David Wallon, Gaël Nicolas, Matthew Seaman, Cyril Pottier, Sophia Y. Breusegem, Premendu P. Mathur, Pranitha Jenardhanan, Kilan Le Guennec, Aamir S. Mukadam, Olivier Quenez, Sophie Coutant, Simon Rousseau, A-C Richard, Anne Boland, J.-F. Deleuze, Thierry Frébourg, Didier Hannequin, Dominique Campion, CNR-MAJ collaborators
Related Papers
- → Lack of Genetic Associations of Alpha-1-Antichymotrypsin Polymorphism with Alzheimer-Type Neuropathological Changes or Sporadic Alzheimer’s Disease(1999)12 cited
- Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.(1990)
- Laboratory diagnostic tests for Alzheimer's disease.(1989)
- → Quantitative Assessment of ALZ-50 Immunoreactivity in Alzheimer's Disease(1991)5 cited
- APOLIPOPROTEIN-E AND ALZHEIMERS-DISEASE - ALLELE FREQUENCY AND CLINICAL IMPAIRMENT(1994)